BioHybrid Solutions Funding & Investors
BioHybrid Solutions LLC (BHS) is a Carnegie Mellon University spin-off, focused on next-generation protein-polymer biotherapeutics as alternatives to PEGylation. A fast-growing company with a network of committed partners and collaborators working to deliver the next generation of biotherapeutics.
biohybridsolutions.comTotal Amount Raised: $1,317,796
BioHybrid Solutions Funding Rounds
Seed
$150,000
Seed Investors
Innovation WorksCreative Destruction LabGrant
$742,796
Grant Investors
National Science Foundation (NSF)Grant
$225,000
Grant Investors
National Science Foundation (NSF)Seed
$200,000
Seed Investors
Innovation Works
Funding info provided by Diffbot.